Report Detail

Other Global Neuromodulation Devices Market Insights, Forecast to 2025

  • RnM2883573
  • |
  • 15 July, 2020
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Other

Neuromodulation Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Neuromodulation Devices market is segmented into
Deep Brain Stimulation (DBS)
Spinal Cord Stimulation (SCS)
Vagus Nerve Stimulation (VNS)
Sacral Nerve Stimulation (SNS)
Gastric Electrical Stimulation (GES)

Segment by Application, the Neuromodulation Devices market is segmented into
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other

Regional and Country-level Analysis
The Neuromodulation Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Neuromodulation Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Neuromodulation Devices Market Share Analysis

Neuromodulation Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Neuromodulation Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Neuromodulation Devices business, the date to enter into the Neuromodulation Devices market, Neuromodulation Devices product introduction, recent developments, etc.
The major vendors covered:
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical


1 Study Coverage

  • 1.1 Neuromodulation Devices Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Neuromodulation Devices Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Neuromodulation Devices Market Size Growth Rate by Type
    • 1.4.2 Deep Brain Stimulation (DBS)
    • 1.4.3 Spinal Cord Stimulation (SCS)
    • 1.4.4 Vagus Nerve Stimulation (VNS)
    • 1.4.5 Sacral Nerve Stimulation (SNS)
    • 1.4.6 Gastric Electrical Stimulation (GES)
  • 1.5 Market by Application
    • 1.5.1 Global Neuromodulation Devices Market Size Growth Rate by Application
    • 1.5.2 Pain Management
    • 1.5.3 Parkinson’s Disease
    • 1.5.4 Urinary and Fecal Incontinence
    • 1.5.5 Epilepsy
    • 1.5.6 Gastroparesis
    • 1.5.7 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Neuromodulation Devices Market Size, Estimates and Forecasts
    • 2.1.1 Global Neuromodulation Devices Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Neuromodulation Devices Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Neuromodulation Devices Production Estimates and Forecasts 2015-2026
  • 2.2 Global Neuromodulation Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Neuromodulation Devices Manufacturers Geographical Distribution
  • 2.4 Key Trends for Neuromodulation Devices Markets & Products
  • 2.5 Primary Interviews with Key Neuromodulation Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Neuromodulation Devices Manufacturers by Production Capacity
    • 3.1.1 Global Top Neuromodulation Devices Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Neuromodulation Devices Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Neuromodulation Devices Manufacturers Market Share by Production
  • 3.2 Global Top Neuromodulation Devices Manufacturers by Revenue
    • 3.2.1 Global Top Neuromodulation Devices Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Neuromodulation Devices Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices Revenue in 2019
  • 3.3 Global Neuromodulation Devices Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Neuromodulation Devices Production by Regions

  • 4.1 Global Neuromodulation Devices Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Neuromodulation Devices Regions by Production (2015-2020)
    • 4.1.2 Global Top Neuromodulation Devices Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Neuromodulation Devices Production (2015-2020)
    • 4.2.2 North America Neuromodulation Devices Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Neuromodulation Devices Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Neuromodulation Devices Production (2015-2020)
    • 4.3.2 Europe Neuromodulation Devices Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Neuromodulation Devices Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Neuromodulation Devices Production (2015-2020)
    • 4.4.2 China Neuromodulation Devices Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Neuromodulation Devices Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Neuromodulation Devices Production (2015-2020)
    • 4.5.2 Japan Neuromodulation Devices Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Neuromodulation Devices Import & Export (2015-2020)

5 Neuromodulation Devices Consumption by Region

  • 5.1 Global Top Neuromodulation Devices Regions by Consumption
    • 5.1.1 Global Top Neuromodulation Devices Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Neuromodulation Devices Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Neuromodulation Devices Consumption by Application
    • 5.2.2 North America Neuromodulation Devices Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Neuromodulation Devices Consumption by Application
    • 5.3.2 Europe Neuromodulation Devices Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Neuromodulation Devices Consumption by Application
    • 5.4.2 Asia Pacific Neuromodulation Devices Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Neuromodulation Devices Consumption by Application
    • 5.5.2 Central & South America Neuromodulation Devices Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Neuromodulation Devices Consumption by Application
    • 5.6.2 Middle East and Africa Neuromodulation Devices Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 UAE

6 Market Size by Type (2015-2026)

  • 6.1 Global Neuromodulation Devices Market Size by Type (2015-2020)
    • 6.1.1 Global Neuromodulation Devices Production by Type (2015-2020)
    • 6.1.2 Global Neuromodulation Devices Revenue by Type (2015-2020)
    • 6.1.3 Neuromodulation Devices Price by Type (2015-2020)
  • 6.2 Global Neuromodulation Devices Market Forecast by Type (2021-2026)
    • 6.2.1 Global Neuromodulation Devices Production Forecast by Type (2021-2026)
    • 6.2.2 Global Neuromodulation Devices Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Neuromodulation Devices Price Forecast by Type (2021-2026)
  • 6.3 Global Neuromodulation Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Neuromodulation Devices Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Neuromodulation Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Medtronic
    • 8.1.1 Medtronic Corporation Information
    • 8.1.2 Medtronic Overview
    • 8.1.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Medtronic Product Description
    • 8.1.5 Medtronic Related Developments
  • 8.2 Boston Scientific
    • 8.2.1 Boston Scientific Corporation Information
    • 8.2.2 Boston Scientific Overview
    • 8.2.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Boston Scientific Product Description
    • 8.2.5 Boston Scientific Related Developments
  • 8.3 Abbott
    • 8.3.1 Abbott Corporation Information
    • 8.3.2 Abbott Overview
    • 8.3.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Abbott Product Description
    • 8.3.5 Abbott Related Developments
  • 8.4 LivaNova
    • 8.4.1 LivaNova Corporation Information
    • 8.4.2 LivaNova Overview
    • 8.4.3 LivaNova Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 LivaNova Product Description
    • 8.4.5 LivaNova Related Developments
  • 8.5 Nevro
    • 8.5.1 Nevro Corporation Information
    • 8.5.2 Nevro Overview
    • 8.5.3 Nevro Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Nevro Product Description
    • 8.5.5 Nevro Related Developments
  • 8.6 NeuroPace
    • 8.6.1 NeuroPace Corporation Information
    • 8.6.2 NeuroPace Overview
    • 8.6.3 NeuroPace Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 NeuroPace Product Description
    • 8.6.5 NeuroPace Related Developments
  • 8.7 Beijing Pins
    • 8.7.1 Beijing Pins Corporation Information
    • 8.7.2 Beijing Pins Overview
    • 8.7.3 Beijing Pins Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Beijing Pins Product Description
    • 8.7.5 Beijing Pins Related Developments
  • 8.8 Synapse Biomedical
    • 8.8.1 Synapse Biomedical Corporation Information
    • 8.8.2 Synapse Biomedical Overview
    • 8.8.3 Synapse Biomedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Synapse Biomedical Product Description
    • 8.8.5 Synapse Biomedical Related Developments

9 Neuromodulation Devices Production Forecast by Regions

  • 9.1 Global Top Neuromodulation Devices Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Neuromodulation Devices Regions Forecast by Production (2021-2026)
  • 9.3 Key Neuromodulation Devices Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Neuromodulation Devices Consumption Forecast by Region

  • 10.1 Global Neuromodulation Devices Consumption Forecast by Region (2021-2026)
  • 10.2 North America Neuromodulation Devices Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Neuromodulation Devices Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Neuromodulation Devices Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Neuromodulation Devices Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Neuromodulation Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Neuromodulation Devices Sales Channels
    • 11.2.2 Neuromodulation Devices Distributors
  • 11.3 Neuromodulation Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Neuromodulation Devices Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Neuromodulation Devices Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Neuromodulation Devices Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on Neuromodulation Devices . Industry analysis & Market Report on Neuromodulation Devices is a syndicated market report, published as Global Neuromodulation Devices Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Neuromodulation Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,920.00
    5,880.00
    7,840.00
    4,576.60
    6,864.90
    9,153.20
    773,906.00
    1,160,859.00
    1,547,812.00
    408,807.00
    613,210.50
    817,614.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report